Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP252916.RAUfuSb19Y7PFVmjFPN6Fg6rRA5bRtMiIeDwGsObOEgHg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP252916.RAUfuSb19Y7PFVmjFPN6Fg6rRA5bRtMiIeDwGsObOEgHg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP252916.RAUfuSb19Y7PFVmjFPN6Fg6rRA5bRtMiIeDwGsObOEgHg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP252916.RAUfuSb19Y7PFVmjFPN6Fg6rRA5bRtMiIeDwGsObOEgHg130_provenance.
- befree-20150227 importedOn "2015-02-27" NP252916.RAUfuSb19Y7PFVmjFPN6Fg6rRA5bRtMiIeDwGsObOEgHg130_provenance.
- NP252916.RAUfuSb19Y7PFVmjFPN6Fg6rRA5bRtMiIeDwGsObOEgHg130_assertion wasGeneratedBy ECO_0000203 NP252916.RAUfuSb19Y7PFVmjFPN6Fg6rRA5bRtMiIeDwGsObOEgHg130_provenance.
- NP252916.RAUfuSb19Y7PFVmjFPN6Fg6rRA5bRtMiIeDwGsObOEgHg130_assertion wasDerivedFrom befree-20150227 NP252916.RAUfuSb19Y7PFVmjFPN6Fg6rRA5bRtMiIeDwGsObOEgHg130_provenance.
- NP252916.RAUfuSb19Y7PFVmjFPN6Fg6rRA5bRtMiIeDwGsObOEgHg130_assertion SIO_000772 17986858 NP252916.RAUfuSb19Y7PFVmjFPN6Fg6rRA5bRtMiIeDwGsObOEgHg130_provenance.
- NP252916.RAUfuSb19Y7PFVmjFPN6Fg6rRA5bRtMiIeDwGsObOEgHg130_assertion evidence source_evidence_literature NP252916.RAUfuSb19Y7PFVmjFPN6Fg6rRA5bRtMiIeDwGsObOEgHg130_provenance.
- NP252916.RAUfuSb19Y7PFVmjFPN6Fg6rRA5bRtMiIeDwGsObOEgHg130_assertion description "[Methylation of ASC/TMS1 was more common in right-sided tumors (p = 0.02), concordant with hMLH1 methylation (p = 0.03) and is a late stage event, occurring in 0 of 18 tubular adenomas, 0 of 12 villous adenomas, 2 of 44 (5%) Stage 1 cancers, 8 of 31 (26%) Stage 2 cancers, 8 of 21 (38%) Stage 3 cancers and 2 of 19 (11%) Stage 4 cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252916.RAUfuSb19Y7PFVmjFPN6Fg6rRA5bRtMiIeDwGsObOEgHg130_provenance.